Weight loss drug research,low carb diet can i eat oatmeal zucchini,types of diet pills - Step 2

07.10.2013
Arena’s shares dropped by 56% after a rumors hit the market that Lorcaserin will be rejected.
The Food and Drug Administration has approved a new medication to treat moderate to severe binge eating disorder in adults. Marketed under the brand name Vyvanse, lisdexamfetamine dimesylate is a first of its kind prescription drug specifically indicated for binge eating disorder, according to a news release from The Obesity Society.
Although many people who seek obesity treatment report some degree of binge eating, only 7 to 10 percent of them meet the clinical criteria for binge eating disorder or BED.
Research shows that obesity is a far more complex condition than simply being a matter of eating less and exercising more.
Although many people overeat from time to time, it does not necessarily mean they have binge eating disorder.


This is not the first and probably not the last weight loss drug which fails to win an approval from the American FDA. The FDA considers that the risk of cancer definitely exceeds the weight loss results provided by the pill. Check the below Youtube video which illustrates the producers plan to market their potential weight loss drug and the amount of money involved with this deal. In most cases, obesity is chronic and challenging to treat and puts individuals at risk for more than 30 health conditions. Federal health authorities also note that binge eating disorder is different from bulimia nervosa, which is when people binge eat on a regular basis but then proceed to engage in unhealthy behaviors such as vomiting, fasting, over-exercising or using laxatives and diuretics to compensate. The rejection has been motivated because of a possible serious side-effect caused by the pill, which is called cancer.


They intend to commit now to several studies in order to prove that their drug is worth for approval. However, if they manage to convince the FDA officials to change their mind, Lorcaserin can only reach the market in 2015, in case of a potential approval. Side-effects including increased risks of heart attacks and cancer compared with minimal to medium weight loss efficiency have forced the Food and Drug Administration to reject all the pills proposed for approval.



Meal plans for fat loss muscle gain omelette
How much weight can i lose in a week by not eating carbs
Best liquid diet plan to lose weight fast
Best exercise to help lose weight fast


Comments to «Weight loss drug research»

  1. HEYATQISA_DEYMEZQIZA writes:
    Months, but as soon as I "cheated" and this or any training or weight.
  2. 562 writes:
    Supportive athletic sneakers i'd still wherever near.